TY - JOUR
T1 - Editor's Choice – European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Consensus Statement on Ascending Thoracic Endovascular Aortic Repair
AU - Trimarchi, Santi
AU - Czerny, Martin
AU - Haulon, Stéphan
AU - van Herwaarden, Joost A.
AU - de Kort, Jasper F.
AU - Roselli, Eric E.
AU - Schermerhorn, Mark L.
AU - Upchurch, Gilbert R.
AU - Wanhainen, Anders
N1 - Publisher Copyright:
© 2025 European Society for Vascular Surgery
PY - 2025/7
Y1 - 2025/7
N2 - Objective: Diseases of the ascending thoracic aorta, including type A aortic dissection, type A intramural haematoma, fusiform aneurysm, pseudoaneurysms, and penetrating aortic ulcer, pose significant management challenges due to the complex anatomy and high pressure haemodynamics of the ascending aorta. While open surgical repair is the gold standard, efforts to improve access to therapy and reduce invasiveness have driven interest in thoracic endovascular aortic repair adapted for the ascending aorta (aTEVAR). However, the lack of evidence has led to variability in patient selection, procedural approaches, and outcomes. This consensus document aims to provide recommendations on the use of aTEVAR for the treatment of ascending thoracic aortic diseases. Methods: Pre-defined criteria were applied to develop the most relevant clinical questions, and a systematic literature review was performed. Consensus statements were developed using a nominal group technique, including structured Delphi type methodology involving two online meetings, followed by three survey rounds and a final in person meeting of the multidisciplinary panel of experts. Results: The consensus document provides aTEVAR recommendations in relation to topics including patient selection, risk stratification, procedural planning (e.g., landing zones and stent graft sizing), intra-operative strategies, and post-operative management. The document also highlights gaps in evidence and identifies areas requiring further research. Conclusion: This document provides expert consensus based guidance on aTEVAR as a treatment option for selected patients with ascending thoracic aortic diseases, particularly those at high surgical risk. By providing standardised recommendations and emphasising multidisciplinary care, the document aims to reduce variability in clinical practice, enhance procedural safety, and improve patient outcomes. Future research should focus on optimisation of procedural techniques, device specific data, long term outcomes, improving patient selection, and direct comparison of aTEVAR with matched cohorts undergoing open repair.
AB - Objective: Diseases of the ascending thoracic aorta, including type A aortic dissection, type A intramural haematoma, fusiform aneurysm, pseudoaneurysms, and penetrating aortic ulcer, pose significant management challenges due to the complex anatomy and high pressure haemodynamics of the ascending aorta. While open surgical repair is the gold standard, efforts to improve access to therapy and reduce invasiveness have driven interest in thoracic endovascular aortic repair adapted for the ascending aorta (aTEVAR). However, the lack of evidence has led to variability in patient selection, procedural approaches, and outcomes. This consensus document aims to provide recommendations on the use of aTEVAR for the treatment of ascending thoracic aortic diseases. Methods: Pre-defined criteria were applied to develop the most relevant clinical questions, and a systematic literature review was performed. Consensus statements were developed using a nominal group technique, including structured Delphi type methodology involving two online meetings, followed by three survey rounds and a final in person meeting of the multidisciplinary panel of experts. Results: The consensus document provides aTEVAR recommendations in relation to topics including patient selection, risk stratification, procedural planning (e.g., landing zones and stent graft sizing), intra-operative strategies, and post-operative management. The document also highlights gaps in evidence and identifies areas requiring further research. Conclusion: This document provides expert consensus based guidance on aTEVAR as a treatment option for selected patients with ascending thoracic aortic diseases, particularly those at high surgical risk. By providing standardised recommendations and emphasising multidisciplinary care, the document aims to reduce variability in clinical practice, enhance procedural safety, and improve patient outcomes. Future research should focus on optimisation of procedural techniques, device specific data, long term outcomes, improving patient selection, and direct comparison of aTEVAR with matched cohorts undergoing open repair.
KW - Ascending aorta
KW - Ascending aortic disease
KW - Ascending thoracic endovascular aortic repair
KW - aTEVAR
KW - Thoracic endovascular aortic repair
UR - https://www.scopus.com/pages/publications/105008808884
U2 - 10.1016/j.ejvs.2025.05.023
DO - 10.1016/j.ejvs.2025.05.023
M3 - Article
C2 - 40409456
AN - SCOPUS:105008808884
SN - 1078-5884
VL - 70
SP - 10
EP - 23
JO - European Journal of Vascular and Endovascular Surgery
JF - European Journal of Vascular and Endovascular Surgery
IS - 1
ER -